Arthritis

Citations 1-9 of 9 total displayed.

Most recent content (1 Sep 2011):

Commentaries
Inhibition of Osteoclast Differentiation by the Interleukin (IL)-1 Family Cytokine IL-33

Gaby Palmer
IBMS BoneKEy 2011; 8: 415-419. [Full text] [PDF]  

Past content (since Jan 2007):

Perspectives
New Insights into the Biology of Glucocorticoid-Induced Osteoporosis

Nancy E. Lane and Wei Yao
IBMS BoneKEy 2011; 8: 229-236. [Abstract] [Full text] [PDF]  

Perspectives
Anti-TNFα Therapy and Prevention of Bone Loss in Rheumatoid Arthritis

Christian Roux
IBMS BoneKEy 2011; 8: 154-158. [Abstract] [Full text] [PDF]  

Commentaries
Costimulatory Blockade to Prevent Osteoclastogenesis, Inflammation, or Both?

Julia F. Charles and Mary C. Nakamura
IBMS BoneKEy 2010; 7: 287-290. [Full text] [PDF]  

Commentaries
RANKing Bone Resorption Versus Inflammation: Infection Makes the Decision

Sylvie Ferrari-Lacraz and Danielle Burger
IBMS BoneKEy 2010; 7: 156-160. [Full text] [PDF]  

Perspectives
The Genetic Predisposition to Osteoarthritis

Ana M. Valdes and Timothy D. Spector
IBMS BoneKEy 2009; 6: 181-189. [Abstract] [Full text] [PDF]  

Perspectives
Effects of RANKL Inhibition on Inflammation and Immunity

Sylvie Ferrari-Lacraz and Serge Ferrari
IBMS BoneKEy 2009; 6: 116-126. [Abstract] [Full text] [PDF]  

NEWS
Denosumab and the Treatment of Rheumatoid Arthritis: In an Occupied Field, Where Will a RANKL Inhibitor Fit In?

Neil A. Andrews
IBMS BoneKEy 2008; 5: 351-356. [Full text] [PDF]  

Perspectives
New Biochemical Markers of Cartilage Turnover in Osteoarthritis: Recent Developments and Remaining Challenges

Patrick Garnero
BoneKEy-Osteovision 2007; 4: 7-18. [Abstract] [Full text] [PDF]